Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01137539 · ClinicalTrials.gov registry record · NA

TVT-SECUR as an Office-based Procedure

A NA study of Urinary Incontinence and Stress Urinary Incontinence, sponsored by Michigan Institution of Women's Health PC.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT01137539 is a NA study of Urinary Incontinence and Stress Urinary Incontinence that has completed, run by Michigan Institution of Women's Health PC. The registered enrollment target is 50 participants, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01137539, a NA study of Urinary Incontinence and Stress Urinary Incontinence, has completed, sponsored by Michigan Institution of Women's Health PC.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study to assess the feasibility and success of performing the TVT-Secur in the office setting. Endpoints would be success, complications, and patient and physician acceptance of the procedure. Success would be assessed by validated questionnaires. This is a prospective single arm study of 50 patients who will have the TVT-Secur procedure done in the office under local anesthesia. They will be followed for a period of 3 years.

Interventions

  • DEVICE Gynecare TVT-SECUR system

Study Locations (1)

Michigan

  • Advanced Urogynecology of Michigan PC - Dearborn

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2008-10
Est. Completion 2012-10
Phase NA

What the Registry Record Tells You About NCT01137539

The ClinicalTrials.gov registry entry for NCT01137539 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (81% lower). The listed sponsor is Michigan Institution of Women's Health PC, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Gynecare TVT-SECUR system is the first listed.

NCT01137539 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT01137539 about?

NCT01137539 is a clinical study titled "TVT-SECUR as an Office-based Procedure". This is a pilot study to assess the feasibility and success of performing the TVT-Secur in the office setting. Endpoints would be success, complications, and patient and physician acceptance of the procedure. Success would be assessed by validated questionnaires. This is a prospective single arm st...

What is the current status of trial NCT01137539?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-10. Estimated completion is 2012-10.

What conditions does trial NCT01137539 study?

This clinical trial studies the following conditions: Urinary Incontinence, Stress Urinary Incontinence.

What interventions are being tested in trial NCT01137539?

The interventions under investigation include: Gynecare TVT-SECUR system (DEVICE).

Who is sponsoring clinical trial NCT01137539?

This trial is sponsored by Michigan Institution of Women's Health PC, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01137539 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.